Dapansutrile mitigates concanavalin A- induced autoimmune hepatitis: Involvement of NLRP3/IL-1β and JNK/ p38 MAPK pathways
Our results showed that intraperitoneal administration of Dapan could be a therapeutic opportunity to inhibit the development of AIH via inhibition of inflammatory pathways.
Authors
- Dalia H. El‐Kashef (ORCID: https://orcid.org/0000-0002-0021-5533)
- Fahad Alenezi
- Marwa E. Abdelmageed (ORCID: https://orcid.org/0000-0003-2283-5327)
- Manar A. Nader (ORCID: https://orcid.org/0000-0002-8590-2622)
Institutions
- Mansoura University (EG)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.biopha.2025.118026
- Citations
- 5
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 6.61
Funders
- Mansoura University